Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
NCT02910219
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Crofelemer
Sponsor
Sandra Swain
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]